Norwalk, CT, United States of America

James J Mencel

This inventor holds 1 USPTO granted patent. Top assignee: Rorer Pharmaceutical Corporation. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James J Mencel. Retrieved from https://idiyas.com/inventor/james-j-mencel-iqdje88m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of James J. Mencel: Advancements in Antihypertensive Pharmaceuticals

Introduction: James J. Mencel, a noteworthy inventor hailing from Norwalk, CT, has made significant contributions to the field of pharmaceuticals. With a focus on antihypertensive derivatives, Mencel has dedicated his efforts to developing compounds that promise to provide better health outcomes for individuals suffering from hypertension.

Latest Patents: Mencel holds a valuable patent for "Antihypertensive Derivatives - Compounds Having the General Structure ##STR1## and Their Pharmaceutically Acceptable Salts," which exhibit notable antihypertensive activity. This innovation strives to enhance therapeutic options available in the market, bolstering the fight against high blood pressure.

Career Highlights: Throughout his career, Mencel has been associated with Rorer Pharmaceutical Corporation, where he has contributed greatly to drug development and research. His innovative mindset and dedication to improving healthcare outcomes are evident in his work, demonstrating his expertise in the pharmaceutical field.

Collaborations: Mencel has collaborated with esteemed colleagues such as Edward S. Neiss and John T. Suh. These partnerships have fostered a productive environment for innovation and have led to advancements in medical science, particularly in the area of antihypertensive therapies.

Conclusion: James J. Mencel’s work exemplifies the spirit of innovation and dedication in the pharmaceutical industry. His patent on antihypertensive derivatives is a testament to his commitment to improving the quality of life for many patients confronting hypertension. As he continues his work at Rorer Pharmaceutical Corporation, Mencel is sure to inspire future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…